Inquire About a Product| Product: | Dovitinib-d8 | ||||
|---|---|---|---|---|---|
| Catalog Number: | D24858 | ||||
| Synonyms: | 4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone-d8 | ||||
| Pricing: |
|
||||
| Formula: | C21H13D8FN6O | ||||
| Molecular Weight: | 400.48 | ||||
| Structure: |
|
||||
| Category: | Anti-cancer compounds | ||||
| Literature References: |
Angevin, E., Grunwald, V., Ravaud, A., Castellano, D.E., Lin, C.C., Gshwend, J.E., Harzstark, A.L., Chang, J., Wang, Y., Shi, M.M., Escudier, B.J., A phase II study of dovitinib (TKI258), an FGFR- and VEGFR-inhibitor, in patients with advanced or metastatic renal cell cancer (mRCC). Journal of Clinical Oncology, 2011, 29(15):4551. |
||||
| MSDS: | |||||
| Applications: | A labeled inhibitor of angiogenic factors. An antineoplastic. |